Medical Doctor Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Mitchell Lyons

Plastic Surgery Las Vegas, NV Medical Doctor

NPI 1043716251 CMS profile 11555573

9950 W Flamingo Rd Ste 105, Las Vegas, NV 89147

Open in the dashboard

General payments

$2,119

33 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mitchell Lyons of Las Vegas, NV is reported in the CMS Open Payments database as having received $2,119 across 33 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 51st percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $657 15
2024 General $1,444 17
2023 General $18 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mitchell Lyons
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Mitchell Lyons were reported at $657. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Mitchell Lyons Plastic Surgery median Middle half National median
2019 $0 $371 $122–$1,483 $163
2020 $0 $158 $52–$438 $114
2021 $0 $249 $87–$752 $132
2022 $0 $274 $102–$793 $149
2023 $18 $299 $113–$891 $160
2024 $1,444 $361 $124–$1,062 $164
2025 $657 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. AbbVie, Inc. $1,291 13 payments
  2. Motiva USA, LLC $220 2 payments
  3. Mentor Worldwide LLC $157 3 payments
  4. AxoGen $103 1 payment
  5. Musculoskeletal Transplant Foundation Inc. $97 1 payment
  6. LEO Pharma Inc. $49 3 payments
  7. Janssen Biotech, Inc. $41 2 payments
  8. E.R. Squibb & Sons, L.L.C. $34 2 payments
  9. UCB, Inc. $32 1 payment
  10. Stryker Corporation $31 2 payments
  11. Other $64 3 payments

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Food and Beverage $1,671 32 payments
  2. Travel and Lodging $448 1 payment
Products named General payments · program years 2023–2025
  1. NATRELLE SALINE-FILLED BREAST IMPLANTS $1,812 14 payments
  2. REVOLVE $696 4 payments
  3. STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS $696 4 payments
  4. Motiva Implant Matrix $220 2 payments
  5. ALLODERM $175 3 payments
  6. MENTOR MemoryGel Resterilizable Gel Sizer $133 2 payments
  7. Avance Nerve Graft $103 1 payment
  8. AxoGuard Nerve Connector $103 1 payment
  9. AXOGUARD NERVE PROTECTOR $103 1 payment
  10. Axoguard HA+ Nerve Protector $103 1 payment
  11. Other $397 16 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 33 billing codes

Paid by Medicare

$130,450

Medicare's payments for the services billed

Medicare patients

30

Average age 77

Services billed

142

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 73%
Arthritis 63%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

33 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record